Tag
Mangalam Drugs and Organics Limited
2 articles
Mangalam Drugs Q2 FY27 Net Loss ₹7.21 Crore
Mangalam Drugs reported a standalone net loss of ₹7.21 crore for Q2 FY27, with revenue of ₹79.39 crore.
Two consortium bank accounts classified as NPAs, with Bank of Baroda issuing a ₹26.72 crore SARF
Mangalam Drugs AGM Notice Web Link Dispatch
Mangalam Drugs dispatched physical letters containing weblinks to its Annual Report and 53rd AGM notice to shareholders without registered email addresses.
The 53rd AGM is scheduled for September 23,